Health
UAE company nears end of Chinese Covid-19 vaccine trial – Devdiscourse
He said G42 has distribution and manufacturing agreements with Sinopharm and hopes to provide the UAE and other regional states with the vaccine, especially tho…
A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a representative said. The trial, which began in mid-July, is a partnership between Sinopharm’s China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).
The vaccine uses an inactivated virus; a well-known technology which has been used against diseases such as influenza and measles. T…
-
General21 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business17 hours ago10 ASX shares to buy after the market selloff
-
General20 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Business17 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…